Digestive Diseases and Sciences

, Volume 55, Issue 7, pp 2089–2094 | Cite as

Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD Score

  • Andrew L. Samuelson
  • Maximilian Lee
  • Ahmad Kamal
  • Emmet B. Keeffe
  • Aijaz Ahmed
Original Article

Abstract

Background

Patients with diabetes mellitus overall experience worse health outcomes than non-diabetics, but whether this is true among recipients of liver transplantation still remains unclear. The aim of this study was to compare the mortality of diabetic and non-diabetic patients following liver transplantation.

Methods

We conducted a retrospective analysis of 530 adult patients undergoing liver transplantation at Stanford University Medical Center from February 1995 to July 2006. Information on diabetes mellitus was available for 431 patients; 96 patients who had acute liver failure (n = 17), combined liver and kidney transplantation (n = 28), or died prior to discharge (n = 51) were excluded from analysis.

Results

Over a mean follow-up of 4.5 years, survival was 81% in the diabetic group and 94% among controls (p = <0.0001). After controlling for age (mean ± SD: 54.4 ± 7.6 in diabetics, 50.1 ± 9.6 in controls), body mass index (28.6 ± 6.6 in diabetics, 27.1 ± 5.4 in controls), presence of hepatitis C, and MELD score (17 ± 9.6 in diabetics, 19 ± 10.2 in controls), diabetes mellitus remained a significant predictor of death (HR 3.11, p = 0.01).

Conclusions

Diabetes mellitus is an independent risk factor for mortality following liver transplantation. Further investigation of this relationship should focus on the impact of more intensive pre- and post-liver transplantation glucose control, cardiovascular risk factor reduction, and the effects of accelerated atherosclerosis in the setting of immune suppression.

Keywords

Liver transplantation Diabetes mellitus Mortality after transplantation 

References

  1. 1.
    Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1997–2006. Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; 2007.Google Scholar
  2. 2.
    Kashyap A, Jain J, Demetris K, et al. Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc. 2001;33:1482–1483.CrossRefPubMedGoogle Scholar
  3. 3.
    CDC. National Diabetes Fact Sheet: general information and national estimates on diabetes in the United States, 2005. Available at: http://www.cdc.gov/diabetes/pubs/factsheet05.htm. Last accessed: March 2, 2008.
  4. 4.
    Petrides AS, Vogt C, Schulze-Berge D, Matthews DE, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology. 1994;19:616–627.CrossRefPubMedGoogle Scholar
  5. 5.
    Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol. 2000;32:209–217.CrossRefPubMedGoogle Scholar
  6. 6.
    Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 2004;126:840–848.CrossRefPubMedGoogle Scholar
  7. 7.
    Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation. 2006;82:1673–1676.CrossRefPubMedGoogle Scholar
  8. 8.
    van Hooff JP, Christiaans MHL, van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation. 2005;79:1465–1469.CrossRefPubMedGoogle Scholar
  9. 9.
    Weir MW, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34:1–13.CrossRefPubMedGoogle Scholar
  10. 10.
    Markell M. Clinical impact of posttransplant diabetes mellitus. Transplantation Proc. 2001;33(5A Suppl):19S–22S.CrossRefGoogle Scholar
  11. 11.
    Wilson RM. Neutrophil function in diabetes. Diabet Med. 1986;3:509–512.CrossRefPubMedGoogle Scholar
  12. 12.
    Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35:105–109.CrossRefPubMedGoogle Scholar
  13. 13.
    Menon KVN, Nyberg SL, Harmsen WS, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant. 2004;4:819–825.CrossRefGoogle Scholar
  14. 14.
    Wahlstrom HE, Cooper J, Gores G, Rosen C, Wiesner R, Krom RAF. Survival after liver transplantation in diabetics. Transplant Proc. 1991;23:1565–1566.PubMedGoogle Scholar
  15. 15.
    Trail KC, Stratta RJ, Larsen JL, et al. Results of liver transplantation in diabetic recipients. Surgery. 1993;114:650–658.PubMedGoogle Scholar
  16. 16.
    Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P, Pirenne J. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation. 1999;68:530–535.CrossRefPubMedGoogle Scholar
  17. 17.
    Blanco JJ, Herrero JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl. 2001;7:226–233.CrossRefPubMedGoogle Scholar
  18. 18.
    John PR, Thuluvath PJ. Outcome of liver transplantation in patients with diabetes mellitus: a case control study. Hepatology. 2001;34:799–895.CrossRefGoogle Scholar
  19. 19.
    Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation. 2002;74:1007–1012.CrossRefPubMedGoogle Scholar
  20. 20.
    Velidedeoglu E, Mange KC, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV− recipients. Transplantation. 2004;77:1834–1842.CrossRefPubMedGoogle Scholar
  21. 21.
    Saab S, Wang V, Ibrahim A, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003;9:473–476.CrossRefPubMedGoogle Scholar
  22. 22.
    Habib A, Berk B, Chang C, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl. 2006;12:440–447.CrossRefPubMedGoogle Scholar
  23. 23.
    Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–932.CrossRefPubMedGoogle Scholar
  24. 24.
    Pinhas-Hamiel O, Zeitler P. The global spread of type II diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700.CrossRefPubMedGoogle Scholar
  25. 25.
    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053.CrossRefPubMedGoogle Scholar
  26. 26.
    Thuluvath PJ. When is diabetes mellitus a relative or absolute contraindication to liver transplantation? Liver Transpl. 2005;11(suppl):S25–S29.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Andrew L. Samuelson
    • 1
  • Maximilian Lee
    • 1
  • Ahmad Kamal
    • 1
    • 2
  • Emmet B. Keeffe
    • 1
  • Aijaz Ahmed
    • 1
  1. 1.Division of Gastroenterology and Hepatology, Department of MedicineStanford University Medical CenterStanfordUSA
  2. 2.Division of GastroenterologySanta Clara Valley Medical CenterSan JoseUSA

Personalised recommendations